Study to Evaluate Clinical Efficacy and Safety of Nuvastatic™ – C5OSEW5050ESA in Diabetic Retinopathy.
Condition(s):Diabetic RetinopathyLast Updated:September 22, 2020Unknown status
Hide Studies Not Open or Pending
Condition(s):Diabetic RetinopathyLast Updated:September 22, 2020Unknown status
Condition(s):S-ketamine; Esketamine; Acute Pain; Postoperative Pain; Analgesia; Hyperalgesia; Delirium; Depression, Anxiety; ChildrenLast Updated:March 8, 2024Enrolling by invitation
Condition(s):Breast CancerLast Updated:July 20, 2012Completed
Condition(s):Dental CariesLast Updated:September 16, 2013Completed
Condition(s):Breast CancerLast Updated:August 29, 2011Completed
Condition(s):Metabolic SyndromeLast Updated:February 8, 2024Completed
Condition(s):AutismLast Updated:January 10, 2012Withdrawn
Condition(s):Dietary HabitsLast Updated:April 15, 2022Completed
Condition(s):Parkinson’s Disease; Parkinsonian Disorders; Atypical Parkinson Disease; Progressive Supranuclear Palsy; Multiple System Atrophy; Corticobasal Degeneration; Gait, Frontal; Huntington DiseaseLast Updated:January 4, 2023Active, not recruiting
Condition(s):Obesity; Nonalcoholic Fatty Liver; Diabetes Type 2; HealthyLast Updated:March 28, 2024Not yet recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.